Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07612254 · ClinicalTrials.gov registry record · Phase 1
aPBI Re-irradiation
A Phase 1 study, sponsored by Dartmouth-Hitchcock Medical Center.
- Not yet
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT07612254 is a Phase 1 study that has not yet begun recruiting, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 30 participants.
The verdict
NCT07612254, a Phase 1 study, has not yet begun recruiting, sponsored by Dartmouth-Hitchcock Medical Center.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study is to determine whether acute treatment-associated adverse events following breast re-irradiation with aPBI are acceptably low and to assess local control following breast re-irradiation with aPBI. An exploratory aim is to assess cosmetic outcomes following breast re-irradiation with aPBI.
Interventions
- RADIATION Reirradiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-06-03 |
| Est. Completion | 2033-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07612254
The ClinicalTrials.gov registry entry for NCT07612254 describes a study currently listed as not yet recruiting, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Reirradiation is the first listed.
NCT07612254 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07612254 about?
NCT07612254 is a clinical study titled "aPBI Re-irradiation". This study is to determine whether acute treatment-associated adverse events following breast re-irradiation with aPBI are acceptably low and to assess local control following breast re-irradiation with aPBI. An exploratory aim is to assess cosmetic outcomes following breast re-irradiation with aPBI...
What is the current status of trial NCT07612254?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2026-06-03. Estimated completion is 2033-04.
What interventions are being tested in trial NCT07612254?
The interventions under investigation include: Reirradiation (RADIATION).
Who is sponsoring clinical trial NCT07612254?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.